Skip to main content

Duplex value of caveolin-1 in non-small cell lung cancer: a meta analysis

Familial Cancer volume 13, pages 449–457 (2014)Cite this article

Abstract

Caveolin-1 (Cav-1) may act as a prognostic biomarker in human cancers. This study is prepared to clarify the prognostic value of Cav-1 in patients with non-small cell lung cancer (NSCLC). All eligible articles from China National Knowledge Infrastructure, Pubmed, Highvire, and Science Direct systems were incorporated into this study. We extracted the patients’ clinical characteristics and survival outcomes and performed a meta-analysis to demonstrate the prognostic role of Cav-1 and the correlations between Cav-1 expression and clinical characteristics. Thirteen articles met the inclusion/exclusion criteria. Cav-1 is deregulated in human lung cancers (NSCLC and small cell lung cancer) compared to noncancerous tissues (χ2 = 200.478, p < 0.005), but the difference of expression level of Cav-1 is not significant (χ2 = 2.248, p > 0.005) among different types of NSCLC, such as adenocarcinomas (ADs), squamous cell carcinoma (SCC) and miscellaneous cancers. Cav-1 expression could predict the poor prognosis of patients with NSCLC. The combined hazard ratio (HR, 95 % CI) was 2.00 (1.54, 2.60) for overall survival (OS) and 3.14 (1.68, 5.88) for progression free survival or disease free survival. The combined HR (95 % CI) of OS was 2.29 (1.26, 4.17) for ADs and 3.21 (1.69, 6.09) for SCC. The Cav-1 expression was associated with age, differentiation, primary tumor stage, tumor node metastasis stage, lymph node metastasis, chemotherapeutic response, and other clinical characteristics. We also analyzed the odds ratios of Cav-1 expression in AD and SCC patients by subgroups. Cav-1 plays a duplex role in tumorigenesis and tumor progression. Cav-1 may be another biomarker to predict the prognosis of lung cancers.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

References

  1. Li S, Song KS, Koh SS, Kikuchi A, Lisanti MP (1996) Baculovirusbased expression of mammalian caveolin in Sf21 insect cells. A model system for the biochemical and morphological study of caveolar biogenesis. J Biol Chem 271:28647–28654

    PubMed  Article  CAS  Google Scholar 

  2. Razani B, Woodman SE, Lisanti MP (2002) Caveolae: from cell biology to animal physiology. Pharmacol Rev 54:431–467

    PubMed  Article  CAS  Google Scholar 

  3. Nam KH, Lee BL, Park JH et al (2013) Caveolin 1 expression correlates with poor prognosis and focal adhesion kinase expression in gastric cancer. Pathobiology 80(2):87–94

    PubMed  Article  CAS  Google Scholar 

  4. Tang Y, Zeng X, He F et al (2012) Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer. Med Oncol 29(2):977–984

    PubMed  Article  Google Scholar 

  5. Steffens S, Schrader AJ, Blasig H et al (2011) Caveolin 1 protein expression in renal cell carcinoma predicts survival. BMC Urol 11:25

    PubMed  Article  PubMed Central  Google Scholar 

  6. Parmar MKB, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17:2815–2834

    PubMed  Article  CAS  Google Scholar 

  7. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101

    Google Scholar 

  8. Sunaga N, Miyajima K, Suzuki M, Sato M, White MA, Gazdar AF, Minna JD (2003) P-295 dramatically different roles for caveolin-1 in the development of non-small cell lung cancer (NSCLC) vs. small cell lung cancer (SCLC). Lung Cancer 41(2):166

    Article  Google Scholar 

  9. Gasperi Campani A, Pancotti F, Roncuzzi L (2010) 499 Metastatic lung cancer proliferation is inhibited by caveolin-1 silencing. Eur J Cancer Suppl 8:159

    Article  Google Scholar 

  10. Jun L, Yi H, Hai-yan Z et al (2009) Expression and significance of Caveolin-1 in lung cancer tissue chips. C.S.P. Proceedings of the 2009 academic conference[C], vol 1

  11. Katoa T, Miyamotoa M, Kato K et al (2004) Difference of caveolin-1 expression pattern in human lung neoplastic tissue. Atypical adenomatous hyperplasia, adenocarcinoma and squamous cell carcinoma. Cancer Lett 214:121–128

    Article  Google Scholar 

  12. Zhan P, Shen X-K, Qian Q et al (2012) Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas. Oncol Rep 27:1072–1078

    PubMed  CAS  PubMed Central  Google Scholar 

  13. Yang H-w, Wang E-h (2003) Expression of caveolin-1 and its significance in non-small cell lung cancer. China medical university, China Master’s Theses Full-text Database (CMFD)

  14. Yu J-h, Wei Q, Qi F-j, Xu H-t, Wang E-h (2006) Significance of caveolin-1 expression in primary lung cancer. Chin J Pathol 35(11):664–668

    Google Scholar 

  15. Li M, Chen H, Diao L, Zhang Y, Xia C, Yang F (2010) Caveolin-1 and VEGF-C promote lymph node metastasis in the absence of intratumoral lymphangiogenesis in non-small cell lung cancer. Tumori 96:734–743

    PubMed  Google Scholar 

  16. Ho C-C, Kuo S-H, Huang P-H, Huang H-Y, Yang C-H, Yang P-C (2008) Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy. Lung Cancer 59:105–110

    PubMed  Article  Google Scholar 

  17. Chen HL, Fan LF, Gao J, Ouyang JP, Zhang YX (2011) Differential expression and function of the caveolin-1 gene in non-small cell lung carcinoma. Oncol Rep 25:359–366

    PubMed  Google Scholar 

  18. Moon KC, Lee GK, Yoo S-H, Jeon YK, Chung J-H, Han J, Chung DH (2005) Expression of caveolin-1 in pleomorphic carcinoma of the lung is correlated with a poor prognosis. Anticancer Res 25:4631–4638

    PubMed  CAS  Google Scholar 

  19. Yoo S-H, Park YS, Kim H-R et al (2003) Expression of caveolin-1 is associated with poor prognosis of patients with squamous cell carcinoma of the lung. Lung Cancer 42:195–202

    PubMed  Article  Google Scholar 

  20. Ho C-C, Huang P-H, Huang H-Y, Chen Y-H, Yang P-C, Hsu S-M (2002) Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. Am J Pathol 161(5):1647–1656

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  21. Liu H-x, Xing L-x, Wang H-b, Yang J-q, Sun Y-m (2008) Relationship between expression of caveolin-1 and pERK1/2 and prognosis in non-small cell lung cancer. Chin J Pathol 37(9):615–619

    CAS  Google Scholar 

  22. Fei H, Lan-xiang Z, Jin-chen S, Min Y, Gang Q, Jie Z (2012) Association between caveolin-1 expression and prognosis in squamous cell carcinoma of lung. J Clin Exp Pathol 28(12):1383–1385

    Google Scholar 

  23. Ma H, Chen H, Zhu R et al (2013) Expression of caveolin-1 and its significance in the prognosis of lung squamous cell carcinoma. Chin J Clin Oncol 40(2):93–96

    CAS  Google Scholar 

  24. Ando T, Ishiguro H, Kimura M et al (2007) The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. Oncol Rep 18(3):601–609

    PubMed  CAS  Google Scholar 

  25. Gumulec J, Sochor J, Hlavna M et al (2012) Caveolin-1 as a potential high-risk prostate cancer biomarker. Oncol Rep 27(3):831–841

    PubMed  CAS  Google Scholar 

  26. Bender FC, Reymond MA, Bron C, Quest A (2000) Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res 60:5870–5878

    PubMed  CAS  Google Scholar 

  27. Lisanti MP, Scherer PE, Vidugiriene J et al (1994) Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol 126:111–126

    PubMed  Article  CAS  Google Scholar 

  28. Song KS, Li S, Okamoto T, Quilliam L, Sargiacomo M, Lisanti MP (1996) Copurification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent free purification of caveolae membranes. J Biol Chem 271:9690–9697

    PubMed  Article  CAS  Google Scholar 

  29. Engelman JA, Wycoff CC, Yasuhara S, Song KS, Okamoto T, Lisanti MP (1997) Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J Biol Chem 272:16374–16381

    PubMed  Article  CAS  Google Scholar 

  30. Jenkins RB, Qian J, Lee HK et al (1998) A molecular cytogenetic analysis of 7q31 in prostate cancer. Cancer Res 58:759–766

    PubMed  CAS  Google Scholar 

  31. Galbiati F, Volonté D, Engelman JA, Watanabe G, Burk R, Pestell R, Lisanti MP (1998) Targeted down-regulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 17:6633–6648

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  32. Engelman JA, Chu C, Lin A et al (1998) Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett 428:205–211

    PubMed  Article  CAS  Google Scholar 

  33. Brasaemle DL, Levin DM, Adler-Wailes DC, Londos C (2000) The lipolytic stimulation of 3T3-L1 adipocytes promotes the translocation of hormone-sensitive lipase to the surfaces of lipid storage droplets. Biochim Biophys Acta 1483:251–262

    PubMed  Article  CAS  Google Scholar 

  34. Maglione JE, Moghanaki D, Young LJ et al (2001) Transgenic polyoma middle-T mice model premalignant mammary disease. Cancer Res 61:8298–8305

    PubMed  CAS  Google Scholar 

  35. Ma X, Liu L, Nie W, Li Y, Zhang B, Zhang J, Zhou R (2013) Prognostic role of caveolin in breast cancer: a meta-analysis. Breast 22:462–469

    PubMed  Article  Google Scholar 

  36. Sotgia F, Martinez-Outschoorn UE, Pavlides S, Howell A, Pestell RG, Lisanti MP (2011) Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment. Breast Cancer Res 13:213–226

    PubMed  Article  PubMed Central  Google Scholar 

  37. Williams TM, Lisanti MP (2005) Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 288:C494–C506

    PubMed  Article  CAS  Google Scholar 

  38. Schlegel A, Arvan P, Lisanti MP (2001) Caveolin-1 binding to endoplasmic reticulum membranes and entry into the regulated secretory pathway are regulated by serine phosphorylation. J Biol Chem 276:4398–4408

    PubMed  Article  CAS  Google Scholar 

Download references

Conflict of interest

We declare that the authors have no conflict of interest.

Author information

Affiliations

  1. Department of Thoracic Surgery, West China Hospital, Sichuan University, Guoxuexiang, No. 37, Chengdu, 610041, Sichuan, China

    Dali Chen, Cheng Shen, Heng Du, Yubin Zhou & Guowei Che

Authors
  1. Dali Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cheng Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Heng Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yubin Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guowei Che
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guowei Che.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chen, D., Shen, C., Du, H. et al. Duplex value of caveolin-1 in non-small cell lung cancer: a meta analysis. Familial Cancer 13, 449–457 (2014). https://doi.org/10.1007/s10689-014-9707-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-014-9707-6

Keywords

  • Non-small cell lung cancers
  • Caveolin-1
  • Prognosis
  • Meta-analysis